Skip to main content
Top
Published in: BMC Infectious Diseases 1/2003

Open Access 01-12-2003 | Research article

Conventional and molecular epidemiology of Tuberculosis in Manitoba

Authors: Kym S Blackwood, Assaad Al-Azem, Lawrence J Elliott, Earl S Hershfield, Amin M Kabani

Published in: BMC Infectious Diseases | Issue 1/2003

Login to get access

Abstract

Background

To describe the demographic and geographic distribution of tuberculosis (TB) in Manitoba, thus determining risk factors associated with clustering and higher incidence rates in distinct subpopulations.

Methods

Data from the Manitoba TB Registry was compiled to generate a database on 855 patients with tuberculosis and their contacts from 1992–1999. Recovered isolates of M. tuberculosis were typed by IS6110 restriction fragment length polymorphisms. Bivariate and multivariate logistic regression models were used to identify risk factors involved in clustering.

Results

A trend to clustering was observed among the Canadian-born treaty Aboriginal subgroup in contrast to the foreign-born. The dominant type, designated fingerprint type 1, accounts for 25.8% of total cases and 75.3% of treaty Aboriginal cases. Among type 1 patients residing in urban areas, 98.9% lived in Winnipeg. In rural areas, 92.8% lived on Aboriginal reserves. Statistical models revealed that significant risk factors for acquiring clustered tuberculosis are gender, age, ethnic origin and residence. Those at increased risk are: males (p < 0.05); those under age 65 (p < 0.01 for each age subgroup); treaty Aboriginals (p < 0.001), and those living on reserve land (p < 0.001).

Conclusion

Molecular typing of isolates in conjunction with contact tracing data supports the notion of the largest ongoing transmission of a single strain of TB within the treaty-status population of Canada recorded to date. This data demonstrates the necessity of continued surveillance of countries with low prevalence of the disease in order to determine and target high-risk populations for concentrated prevention and control measures.
Appendix
Available only for authorised users
Literature
2.
go back to reference Piheu JA: Tuberculosis 2000: problems and solutions. Int J Tuberc Lung Dis. 1998, 2: 696-703. Piheu JA: Tuberculosis 2000: problems and solutions. Int J Tuberc Lung Dis. 1998, 2: 696-703.
3.
go back to reference Raviglione MC, Snider DE, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995, 273: 220-226. 10.1001/jama.273.3.220.CrossRefPubMed Raviglione MC, Snider DE, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995, 273: 220-226. 10.1001/jama.273.3.220.CrossRefPubMed
5.
go back to reference Wherret GJ: Tuberculosis in Canada. Ottawa: Royal Commission on Health Services. 1964 Wherret GJ: Tuberculosis in Canada. Ottawa: Royal Commission on Health Services. 1964
6.
go back to reference Canada Communicable Disease Report. Supplement: Proceedings of the national consensus conference on tuberculosis. Health Canada. 1997, 24S2: Canada Communicable Disease Report. Supplement: Proceedings of the national consensus conference on tuberculosis. Health Canada. 1997, 24S2:
7.
go back to reference Long R, ed: Canadian Tuberculosis Standards. Canadian Lung Association and Health Canada. 2000, 5 Long R, ed: Canadian Tuberculosis Standards. Canadian Lung Association and Health Canada. 2000, 5
8.
go back to reference Health Canada: Tuberculosis in the First Nations, 1999. Health Canada, Canada. 1999, (Cat.H35-4/7-1999E) (ISBN 0-662-30044-0) Health Canada: Tuberculosis in the First Nations, 1999. Health Canada, Canada. 1999, (Cat.H35-4/7-1999E) (ISBN 0-662-30044-0)
9.
go back to reference Long R, Njoo H, Hershfield E: Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1993, 160: 1185-1190. Long R, Njoo H, Hershfield E: Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1993, 160: 1185-1190.
10.
go back to reference Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: Tuberculosis in Manitoba: Conventional and molecular epidemiology (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBE Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: Tuberculosis in Manitoba: Conventional and molecular epidemiology (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBE
11.
go back to reference Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: Rural and localized tuberculosis outbreaks in Manitoba (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBE Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: Rural and localized tuberculosis outbreaks in Manitoba (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBE
12.
go back to reference Dimensions Series: Portrait of Aboriginal Population in Canada. Ottawa, ON: Statistics Canada. 1999, [94F0011XCB] Dimensions Series: Portrait of Aboriginal Population in Canada. Ottawa, ON: Statistics Canada. 1999, [94F0011XCB]
13.
go back to reference Live Database 1992–1997, Indian Registry System, Indian and Northern Affairs Canada. Manitoba Region. Live Database 1992–1997, Indian Registry System, Indian and Northern Affairs Canada. Manitoba Region.
14.
go back to reference van-Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993, 31: 406-409.PubMedPubMedCentral van-Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993, 31: 406-409.PubMedPubMedCentral
15.
go back to reference Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA: Molecular strain typing of Mycobacterium tuberculosis to confirm cross- contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993, 31: 1677-82.PubMedPubMedCentral Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA: Molecular strain typing of Mycobacterium tuberculosis to confirm cross- contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993, 31: 1677-82.PubMedPubMedCentral
16.
go back to reference Rhee JT, Tanaka MM, Behr MA, Agasino CB, Paz EA, Hopewell PC, Small PM: Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis. Int J Tuberc Lung Dis. 2000, 4: 1111-1119.PubMed Rhee JT, Tanaka MM, Behr MA, Agasino CB, Paz EA, Hopewell PC, Small PM: Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis. Int J Tuberc Lung Dis. 2000, 4: 1111-1119.PubMed
17.
go back to reference Shafer RW, Small PM, Larkin C, Singh SP, Kelly P, Sierra MF, Schoolnik G, Chirgwin KD: Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment. J Infect Dis. 1995, 171: 170-76.CrossRefPubMed Shafer RW, Small PM, Larkin C, Singh SP, Kelly P, Sierra MF, Schoolnik G, Chirgwin KD: Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment. J Infect Dis. 1995, 171: 170-76.CrossRefPubMed
18.
go back to reference Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: The impact of foreign-born tuberculosis in Manitoba (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBE Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: The impact of foreign-born tuberculosis in Manitoba (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBE
19.
go back to reference Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schechter GF, Daley CL, Schoolnik GK: The epidemiology of tuberculosis in San Francisco. A population based study using conventional and molecular methods. N Eng J Med. 1994, 330: 1703-1709. 10.1056/NEJM199406163302402.CrossRef Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schechter GF, Daley CL, Schoolnik GK: The epidemiology of tuberculosis in San Francisco. A population based study using conventional and molecular methods. N Eng J Med. 1994, 330: 1703-1709. 10.1056/NEJM199406163302402.CrossRef
20.
go back to reference Gaudette LA, Ellis E: Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tuber Lung Dis. 1993, 74: 244-53.CrossRefPubMed Gaudette LA, Ellis E: Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tuber Lung Dis. 1993, 74: 244-53.CrossRefPubMed
21.
go back to reference Yuan L, Carew M, Kwavnick B, Trudel N: Medical services branch tuberculosis program and epidemiologic review. Health Canada, Canada. 1999 Yuan L, Carew M, Kwavnick B, Trudel N: Medical services branch tuberculosis program and epidemiologic review. Health Canada, Canada. 1999
22.
go back to reference Stead WW: Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics?. Int J Tuberc Lung Dis. 2001, 5: 807-814.PubMed Stead WW: Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics?. Int J Tuberc Lung Dis. 2001, 5: 807-814.PubMed
23.
go back to reference Kato-Maeda M, Bifani PJ, Kreiswirth BN, Small PM: The nature and consequence of genetic variability within Mycobacterium tuberculosis. J Clin Invest. 2001, 107: 533-537.CrossRefPubMedPubMedCentral Kato-Maeda M, Bifani PJ, Kreiswirth BN, Small PM: The nature and consequence of genetic variability within Mycobacterium tuberculosis. J Clin Invest. 2001, 107: 533-537.CrossRefPubMedPubMedCentral
24.
go back to reference Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G: Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol. 1999, 162: 6740-46.PubMed Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G: Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol. 1999, 162: 6740-46.PubMed
25.
go back to reference Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, Freedman VH, Kaplan G: Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci USA. 2001, 98: 5752-57. 10.1073/pnas.091096998.CrossRefPubMedPubMedCentral Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, Freedman VH, Kaplan G: Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci USA. 2001, 98: 5752-57. 10.1073/pnas.091096998.CrossRefPubMedPubMedCentral
26.
go back to reference Cowie RL, Sharpe JW: Tuberculosis among immigrants: interval from arrival in Canada to diagnosis. A 5-year study in southern Alberta. CMAJ. 1998, 158: 599-602.PubMedPubMedCentral Cowie RL, Sharpe JW: Tuberculosis among immigrants: interval from arrival in Canada to diagnosis. A 5-year study in southern Alberta. CMAJ. 1998, 158: 599-602.PubMedPubMedCentral
27.
go back to reference Schwartzman K, Menzies D: Tuberculosis screening of immigrants to low-prevalence countries: a cost-effectiveness analysis. Am J Respir Crit Care Med. 2000, 161: 780-789.CrossRefPubMed Schwartzman K, Menzies D: Tuberculosis screening of immigrants to low-prevalence countries: a cost-effectiveness analysis. Am J Respir Crit Care Med. 2000, 161: 780-789.CrossRefPubMed
28.
go back to reference Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC: A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med. 1999, 130: 971-978.CrossRefPubMed Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC: A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med. 1999, 130: 971-978.CrossRefPubMed
29.
go back to reference Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD: Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993–1995 using DNA fingerprinting. Amer J Epidem. 1998, 147: 187-195.CrossRef Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD: Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993–1995 using DNA fingerprinting. Amer J Epidem. 1998, 147: 187-195.CrossRef
Metadata
Title
Conventional and molecular epidemiology of Tuberculosis in Manitoba
Authors
Kym S Blackwood
Assaad Al-Azem
Lawrence J Elliott
Earl S Hershfield
Amin M Kabani
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2003
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-3-18

Other articles of this Issue 1/2003

BMC Infectious Diseases 1/2003 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.